hi Dumaflotchie,I basically agree with you!To me, there is one big question: Why did EXEL management decide diluting and debt financing before the PDUFA date? Or was it a strategical signal to Roche? Or did EXEL make this move in order to be in a stronger position vis à vis Roche? I do not have an answer(s) yet, but I will make some "subcutaneous" investigation with my colleagues at Roche in Basel...You will hear from me, okay!?marsuculix
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra